Full Text
Estimating UK cost-effectiveness thresholds associated with prescribing higher doses of buprenorphine and buprenorphine-naloxone to increase retention in opioid dependence treatment

Abstract

Authors

C. Russell N. McKeganey

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×